Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005381337 | SCV006037221 | uncertain significance | not specified | 2025-02-01 | criteria provided, single submitter | clinical testing | The p.L568P variant (also known as c.1703T>C), located in coding exon 17 of the NEBL gene, results from a T to C substitution at nucleotide position 1703. The leucine at codon 568 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |